456 related articles for article (PubMed ID: 35844558)
21. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for gastric cancer: a 2021 update.
Kole C; Charalampakis N; Tsakatikas S; Kouris NI; Papaxoinis G; Karamouzis MV; Koumarianou A; Schizas D
Immunotherapy; 2022 Jan; 14(1):41-64. PubMed ID: 34784774
[TBL] [Abstract][Full Text] [Related]
23. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer.
Zeng Z; Yang B; Liao Z
Future Oncol; 2021 Apr; 17(12):1553-1569. PubMed ID: 33397136
[TBL] [Abstract][Full Text] [Related]
24. Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Hosseinkhani N; Derakhshani A; Kooshkaki O; Abdoli Shadbad M; Hajiasgharzadeh K; Baghbanzadeh A; Safarpour H; Mokhtarzadeh A; Brunetti O; Yue SC; Silvestris N; Baradaran B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167514
[TBL] [Abstract][Full Text] [Related]
25. Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed.
Hu X; Bian C; Zhao X; Yi T
Front Immunol; 2022; 13():1034903. PubMed ID: 36275669
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for liposarcoma: emerging opportunities and challenges.
Song Z; Lu L; Gao Z; Zhou Q; Wang Z; Sun L; Zhou Y
Future Oncol; 2022 Sep; 18(30):3449-3461. PubMed ID: 36214331
[TBL] [Abstract][Full Text] [Related]
27. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy.
Shang Q; Dong Y; Su Y; Leslie F; Sun M; Wang F
Adv Drug Deliv Rev; 2022 Jun; 185():114308. PubMed ID: 35472398
[TBL] [Abstract][Full Text] [Related]
28. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Shi T; Song X; Wang Y; Liu F; Wei J
Front Immunol; 2020; 11():683. PubMed ID: 32411132
[TBL] [Abstract][Full Text] [Related]
29. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
Ariyasu R; Nishikawa H
Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
[TBL] [Abstract][Full Text] [Related]
30. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.
Liu L; Kshirsagar PG; Gautam SK; Gulati M; Wafa EI; Christiansen JC; White BM; Mallapragada SK; Wannemuehler MJ; Kumar S; Solheim JC; Batra SK; Salem AK; Narasimhan B; Jain M
Theranostics; 2022; 12(3):1030-1060. PubMed ID: 35154473
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy: an alternative promising therapeutic approach against cancers.
Gupta SL; Basu S; Soni V; Jaiswal RK
Mol Biol Rep; 2022 Oct; 49(10):9903-9913. PubMed ID: 35759082
[TBL] [Abstract][Full Text] [Related]
32. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
33. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
34. CAR T‑cell therapy for gastric cancer: Potential and perspective (Review).
Long B; Qin L; Zhang B; Li Q; Wang L; Jiang X; Ye H; Zhang G; Yu Z; Jiao Z
Int J Oncol; 2020 Apr; 56(4):889-899. PubMed ID: 32319561
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy to Treat Cancer.
McCune JS
Clin Pharmacol Ther; 2016 Sep; 100(3):198-203. PubMed ID: 27513619
[TBL] [Abstract][Full Text] [Related]
36. Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.
Sloas C; Gill S; Klichinsky M
Front Immunol; 2021; 12():783305. PubMed ID: 34899748
[TBL] [Abstract][Full Text] [Related]
37. Emerging immunotherapy for the treatment of esophageal cancer.
Jackie Oh S; Han S; Lee W; Lockhart AC
Expert Opin Investig Drugs; 2016 Jun; 25(6):667-77. PubMed ID: 26950826
[TBL] [Abstract][Full Text] [Related]
38. Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
Subhash VV; Yeo MS; Tan WL; Yong WP
J Immunol Res; 2015; 2015():308574. PubMed ID: 26579545
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in immune therapies for gastric cancer.
Olnes MJ; Martinson HA
Cancer Gene Ther; 2021 Sep; 28(9):924-934. PubMed ID: 33664460
[TBL] [Abstract][Full Text] [Related]
40. Novel immunotherapies in multiple myeloma.
Ohmine K; Uchibori R
Int J Hematol; 2022 Jun; 115(6):799-810. PubMed ID: 35583724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
